Safiglipron
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
Shandong Suncadia Medicine Co · Phase 3 · Recruiting · Enrollment 648
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Treatment group A: HRS-7535 | n/r | n/r | n/r | n/r | n/r |
| Treatment group B: Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.